Ge Long Hui A P P·2026-03-30 14:14Core Viewpoint - Shanghai Pharmaceuticals (601607.SH) reported a revenue of 283.58 billion yuan for the year 2025, reflecting a year-on-year growth of 3.03% [1] - The net profit attributable to shareholders reached 5.725 billion yuan, showing a significant year-on-year increase of 25.74% [1] - The net profit excluding non-recurring items was 2.980 billion yuan, which represents a year-on-year decline of 26.68% [1] - The company declared a dividend of 3.5 yuan per share to all shareholders [1] Financial Performance - Total revenue for 2025 was 283.58 billion yuan, up 3.03% compared to the previous year [1] - Net profit attributable to shareholders was 5.725 billion yuan, an increase of 25.74% year-on-year [1] - Net profit excluding non-recurring items decreased to 2.980 billion yuan, down 26.68% from the previous year [1] Dividend Announcement - The company announced a dividend distribution of 3.5 yuan per share for all shareholders [1]